Abstract
The polarization of views on how best to exploit new information from the Human Genome Project for medicine reflects our ignorance of the genetic architecture underlying common diseases: are susceptibility alleles common or rare, neutral or deleterious, few or many? Single-nucleotide polymorphism (SNP) technology is almost in place to dissect such diseases and to create a personalized medicine, but success is critically dependent on the biology and "Nature to be commanded must be obeyed" (Francis Bacon, 1620, Novum Organum).
Original language | English |
---|---|
Pages (from-to) | COMMENT2007 |
Journal | Genome Biology |
Volume | 2 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2001 |